Neuromodulation of the Dorsal Genital Nerve in Persistent Genital Arousal Disorder (NemoPGAD)

Radboud University Medical Center

Status: Completed

Conditions: Arousal Disorders, Sexual

Treatments: Device: Neuromodulation

Study type: Interventional

Funder types: Other

Identifiers

NCT06790563

2023-16221

Details and patient eligibility

About

The goal of this clinical trial is to learn if neuromodulation of the dorsal genital nerve works to treat symptoms related to Persistent Genital Arousal Disorder in women. The main questions it aims to answer are:

What is the effect of neuromodulation on PGAD symptoms in women?

Participants will:

Use a neurosimulator every day for 3 weeks. Keep a diary of their symptoms and the number of times they used the neurostimulator Fill in questionaires

Enrollment: 12 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women with PGAD

Exclusion criteria

• Women < 18 years
• Women not able to handle the neuromodulator
• Women in whom the anatomy of the genitals precludes proper electrode placement

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

12 participants in 1 patient group

Neuromodulation

Experimental group

Description:

Neuromodulation every day, for 3 weeks

Treatment:

Device: Neuromodulation